{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:14:27Z","timestamp":1767849267322,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.atherosclerosis.2021.08.019","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:17:40Z","timestamp":1628723860000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Association between histological severity of Helicobacter pylori infection and cardiovascular risk scores in the Korean population"],"prefix":"10.1016","volume":"333","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-2971","authenticated-orcid":false,"given":"Jaehoon","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyueng-Whan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Kwan","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-1472","authenticated-orcid":false,"given":"Hack-Lyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European society of cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib3","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib6","first-page":"S49","article-title":"ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib7","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.849166","article-title":"Cardiovascular risk prediction: basic concepts, current status, and future directions","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ehj.2003.12.017","article-title":"C-reactive protein elevation and disease activity in patients with coronary artery disease","volume":"25","author":"Arroyo-Espliguero","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrgastro.2013.243","article-title":"Clinical effects of Helicobacter pylori outside the stomach","volume":"11","author":"Franceschi","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/heart.88.1.43","article-title":"Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease","volume":"88","author":"Singh","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/hrt.81.3.245","article-title":"Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease","volume":"81","author":"Danesh","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.97.17.1675","article-title":"Association of virulent Helicobacter pylori strains with ischemic heart disease","volume":"97","author":"Pasceri","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)03079-1","article-title":"Chronic infections and coronary heart disease: is there a link?","volume":"350","author":"Danesh","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib16","article-title":"Chronic gastritis is associated with a decreased high-density lipid level: histological features of gastritis based on the updated Sydney system","volume":"9","author":"Kim","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204762","article-title":"Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: a cross-sectional nationwide multicenter study","volume":"13","author":"Lim","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.dld.2010.04.006","article-title":"The origin of non-H. pylori-related positive Giemsa staining in human gastric biopsy specimens: a prospective study","volume":"43","author":"Seo","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002454","article-title":"Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa","volume":"7","author":"Cullen","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12549","article-title":"Extragastric diseases correlated with Helicobacter pylori","volume":"24","author":"Ponzetto","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1751-2980.2012.00599.x","article-title":"Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review","volume":"13","author":"Tan","year":"2012","journal-title":"J Dig Dis"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s10156-008-0613-4","article-title":"Chronic Helicobacter pylori infection is associated with peripheral arterial disease","volume":"14","author":"Sawayama","year":"2008","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.71.5.437","article-title":"Relation of Helicobacter pylori infection and coronary heart disease","volume":"71","author":"Mendall","year":"1994","journal-title":"Br. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.carpath.2011.09.011","article-title":"Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease","volume":"21","author":"Izadi","year":"2012","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib29","first-page":"822","article-title":"Endothelial \"stunning\" following a brief exposure to endotoxin: a mechanism to link infection and infarction?","volume":"32","author":"Bhagat","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0049-3848(89)90204-1","article-title":"Acute phase reaction, fibrinogen level and thrombus size","volume":"53","author":"Chooi","year":"1989","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib31","first-page":"426","article-title":"Warner-Lambert\/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology","volume":"133","author":"Pober","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0049-3848(82)90291-2","article-title":"Plasma beta-thromboglobulin in severe infection","volume":"26","author":"Rasi","year":"1982","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.ATV.21.3.427","article-title":"Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile","volume":"21","author":"Hoffmeister","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/hrt.75.6.573","article-title":"Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?","volume":"75","author":"Niemela","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2021.08.019_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: a route to targeted therapies","volume":"14","author":"Ruparelia","year":"2017","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021012806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021012806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:47:57Z","timestamp":1758156477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021012806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S0021915021012806"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.08.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between histological severity of Helicobacter pylori infection and cardiovascular risk scores in the Korean population","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}